On Nov. 10, the U.S. Food and Drug Administration (FDA) approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.